422 related articles for article (PubMed ID: 25737124)
21. Rational engineering of Escherichia coli strains for plasmid biopharmaceutical manufacturing.
Gonçalves GA; Bower DM; Prazeres DM; Monteiro GA; Prather KL
Biotechnol J; 2012 Feb; 7(2):251-61. PubMed ID: 21913330
[TBL] [Abstract][Full Text] [Related]
22. Current state-of-the-art in plant-based antibody production systems.
Donini M; Marusic C
Biotechnol Lett; 2019 Mar; 41(3):335-346. PubMed ID: 30684155
[TBL] [Abstract][Full Text] [Related]
23. Systematic metabolic engineering for improvement of glycosylation efficiency in Escherichia coli.
Pandhal J; Desai P; Walpole C; Doroudi L; Malyshev D; Wright PC
Biochem Biophys Res Commun; 2012 Mar; 419(3):472-6. PubMed ID: 22342719
[TBL] [Abstract][Full Text] [Related]
24. Cell line development for biomanufacturing processes: recent advances and an outlook.
Le H; Vishwanathan N; Jacob NM; Gadgil M; Hu WS
Biotechnol Lett; 2015 Aug; 37(8):1553-64. PubMed ID: 25971160
[TBL] [Abstract][Full Text] [Related]
25. Towards a metabolic engineering strain "commons": an Escherichia coli platform strain for ethanol production.
Woodruff LB; May BL; Warner JR; Gill RT
Biotechnol Bioeng; 2013 May; 110(5):1520-6. PubMed ID: 23322646
[TBL] [Abstract][Full Text] [Related]
26. Engineering cell physiology to enhance recombinant protein production in Escherichia coli.
Chou CP
Appl Microbiol Biotechnol; 2007 Sep; 76(3):521-32. PubMed ID: 17571257
[TBL] [Abstract][Full Text] [Related]
27. Toward metabolic engineering in the context of system biology and synthetic biology: advances and prospects.
Liu Y; Shin HD; Li J; Liu L
Appl Microbiol Biotechnol; 2015 Feb; 99(3):1109-18. PubMed ID: 25547833
[TBL] [Abstract][Full Text] [Related]
28. Increasing recombinant protein production in Escherichia coli through metabolic and genetic engineering.
Waegeman H; Soetaert W
J Ind Microbiol Biotechnol; 2011 Dec; 38(12):1891-910. PubMed ID: 21901404
[TBL] [Abstract][Full Text] [Related]
29. Metabolically engineered Escherichia coli for efficient production of glycosylated natural products.
Peirú S; Rodríguez E; Menzella HG; Carney JR; Gramajo H
Microb Biotechnol; 2008 Nov; 1(6):476-86. PubMed ID: 21261868
[TBL] [Abstract][Full Text] [Related]
30. Metabolic engineering of Escherichia coli for the production of phenol from glucose.
Kim B; Park H; Na D; Lee SY
Biotechnol J; 2014 May; 9(5):621-9. PubMed ID: 24115680
[TBL] [Abstract][Full Text] [Related]
31. Host cell proteins in biotechnology-derived products: A risk assessment framework.
de Zafra CL; Quarmby V; Francissen K; Vanderlaan M; Zhu-Shimoni J
Biotechnol Bioeng; 2015 Nov; 112(11):2284-91. PubMed ID: 26010760
[TBL] [Abstract][Full Text] [Related]
32. Biopharmaceutical discovery and production in yeast.
Meehl MA; Stadheim TA
Curr Opin Biotechnol; 2014 Dec; 30():120-7. PubMed ID: 25014890
[TBL] [Abstract][Full Text] [Related]
33. Manufacturing of recombinant therapeutic proteins in microbial systems.
Graumann K; Premstaller A
Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246
[TBL] [Abstract][Full Text] [Related]
34. Biopharmaceuticals derived from genetically modified plants.
Goldstein DA; Thomas JA
QJM; 2004 Nov; 97(11):705-16. PubMed ID: 15496527
[TBL] [Abstract][Full Text] [Related]
35. Proteins behaving badly: emerging technologies in profiling biopharmaceutical aggregation.
Hamrang Z; Rattray NJ; Pluen A
Trends Biotechnol; 2013 Aug; 31(8):448-58. PubMed ID: 23769716
[TBL] [Abstract][Full Text] [Related]
36. Clarification technologies for monoclonal antibody manufacturing processes: Current state and future perspectives.
Singh N; Arunkumar A; Chollangi S; Tan ZG; Borys M; Li ZJ
Biotechnol Bioeng; 2016 Apr; 113(4):698-716. PubMed ID: 26302443
[TBL] [Abstract][Full Text] [Related]
37. Enhanced production of N-acetyl-D-neuraminic acid by multi-approach whole-cell biocatalyst.
Lin BX; Zhang ZJ; Liu WF; Dong ZY; Tao Y
Appl Microbiol Biotechnol; 2013 Jun; 97(11):4775-84. PubMed ID: 23420269
[TBL] [Abstract][Full Text] [Related]
38. Engineering the heterologous expression of lanthipeptides in Escherichia coli by multigene assembly.
Kuthning A; Mösker E; Süssmuth RD
Appl Microbiol Biotechnol; 2015 Aug; 99(15):6351-61. PubMed ID: 25846334
[TBL] [Abstract][Full Text] [Related]
39. Biosynthesis and production of glycosylated flavonoids in Escherichia coli: current state and perspectives.
Kim BG; Yang SM; Kim SY; Cha MN; Ahn JH
Appl Microbiol Biotechnol; 2015 Apr; 99(7):2979-88. PubMed ID: 25750049
[TBL] [Abstract][Full Text] [Related]
40. Metabolic engineering for acetate control in large scale fermentation.
Tao Y; Cheng Q; Kopatsis AD
Methods Mol Biol; 2012; 834():283-303. PubMed ID: 22144366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
